Shares of Oxford BioDynamics PLC jumped on Tuesday after announcing that its EpiSwitch prostate screening test had been validated at its US clinical laboratory,...
If climate change, the signs of which are increasingly evident, forces governments to make radical decisions with a view to turning the ship around,...